| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| osimertinib mechanism of action ppt | 1.85 | 0.9 | 7739 | 99 | 35 |
| osimertinib | 1.26 | 0.4 | 2540 | 62 | 11 |
| mechanism | 0.07 | 0.8 | 122 | 39 | 9 |
| of | 1.03 | 0.8 | 5090 | 100 | 2 |
| action | 0.48 | 0.7 | 5197 | 57 | 6 |
| ppt | 2 | 0.9 | 7835 | 9 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| osimertinib mechanism of action ppt | 0.2 | 0.9 | 1902 | 17 |
| osimertinib mechanism of action pdf | 0.26 | 0.1 | 9417 | 77 |
| osimertinib mechanism of resistance | 0.84 | 0.6 | 3141 | 92 |
| osimertinib duration of action | 1.62 | 0.1 | 358 | 14 |
| resistance mechanisms to osimertinib | 1.9 | 0.6 | 922 | 71 |
| how does osimertinib work | 0.71 | 0.7 | 5311 | 34 |
| osimertinib time to response | 0.73 | 0.1 | 9054 | 20 |
| osimertinib mecanismo de accion | 1.39 | 0.3 | 4621 | 32 |
| primary resistance to osimertinib | 0.44 | 0.5 | 1569 | 57 |
| osimertinib plasma protein binding | 0.77 | 1 | 3814 | 38 |
| mobocertinib mechanism of action | 0.39 | 0.6 | 1264 | 44 |
| is osimertinib an immunosuppressant | 1.01 | 0.7 | 1463 | 90 |
| what is osimertinib used for | 0.92 | 1 | 6679 | 68 |
| osimertinib summary basis of approval | 1.79 | 0.2 | 3230 | 26 |
| osimertinib + savolitinib | 1.45 | 0.4 | 5313 | 69 |
| osimertinib potential side effect | 0.87 | 0.5 | 5772 | 7 |
| osimertinib side effects macmillan | 1.53 | 0.9 | 2102 | 70 |
| osimertinib_1919 | 0.67 | 1 | 7438 | 87 |
| is osimertinib a chemotherapy drug | 1.32 | 0.9 | 7611 | 64 |
| is osimertinib a chemotherapy | 0.24 | 0.5 | 3965 | 17 |
